Nama's AI scorecard currently rates Marsh & McLennan Companies Buy (6.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is MRSH's P/E ratio?

Marsh & McLennan Companies trades at a trailing price-to-earnings ratio of 19.7.

When does MRSH report earnings?

Marsh & McLennan Companies's next scheduled report is on Jan 28, 2027. Analysts expect EPS of $2.22.

What is the MRSH price target?

The median analyst price target from 21 analysts is $201.00, with a range of $180.00 – $230.00.

Is MRSH Shariah compliant?

Nama's AAOIFI-style screen reads Marsh & McLennan Companies as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does MRSH pay a dividend?

Yes — Marsh & McLennan Companies's dividend yield is 1.9%.

Nama Insights

Marsh & McLennan Companies (MRSH)

Financial Services · Insurance Brokers · NYSE

S&P 500

Marsh & McLennan Companies (MRSH) is a Financial Services company in the Insurance Brokers industry. It has a market capitalization of $97.39B, a trailing price-to-earnings ratio of 19.7 and a free-cash-flow yield of 4.9%. Over the most recent reported fiscal year, revenue grew 10.3% and free cash flow per share grew 26.0%. Nama's AI scorecard rates it Buy, 6.5 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Buy · 6.5/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Lagging · -1.6% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-17.4%

How far the last close sits under the highest price of the past five years.

Market cap	$97.39B
Trailing P/E	19.7
Price / book	6.7
Price / sales	3.4
FCF yield	4.9%
Dividend yield	1.9%
Gross margin	42.8%
Operating margin	21.4%
Net margin	14.2%
Revenue growth (YoY)	+10.3%
Revenue growth (3-yr annual)	+9.2%
EPS growth (YoY)	+10.8%
FCF/share growth (YoY)	+26.0%
Beta	0.6
Exchange	NYSE
Sector	Financial Services
Industry	Insurance Brokers

MRSH earnings

Next report: Jan 28, 2027 (Q4 2026, EPS estimate $2.22). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 15, 2026	$2.03	$1.97	+3.0%	$6.86B
Q2 2026	Jul 21, 2026	$2.96	$2.89	+2.4%	$7.40B
Q1 2026	Apr 16, 2026	$3.29	$3.22	+2.2%	$7.60B
Q4 2025	Jan 29, 2026	$2.12	$1.97	+7.6%	$6.59B

MRSH analyst price target

Median target $201.00 from 21 analysts, ranging $180.00 – $230.00.

Insurance Brokers peers

Ticker	Company	Market cap	P/E
AJG	Arthur J. Gallagher	$72.21B	22.2
AON	Aon	$71.03B	18.1
WTW	Willis Towers Watson Public	$30.33B	17.5
BRO	Brown & Brown	$23.92B	16.2
ERIE	Erie Indemnity	$14.28B	21.6
BWIN	Baldwin Insurance Group	$4.50B	17.4
ARX	Accelerant	$4.32B	17.9
CRVL	CorVel	$4.20B	169.7

Explore live MRSH data on Nama Insights →

Recent Congressional trades

Marsh & McLennan Companies trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Kevin Hern	House	Sell	$50,001 - $100,000	Oct 13, 2026
Kevin Hern	House	Sell	$50,001 - $100,000	Oct 13, 2026
Kevin Hern	House	Sell	$1,001 - $15,000	Sep 25, 2026
Kevin Hern	House	Sell	$100,001 - $250,000	Sep 25, 2026
Kevin Hern	House	Sell	$1,001 - $15,000	Sep 25, 2026
Kevin Hern	House	Sell	$1,001 - $15,000	Sep 1, 2026
Alan Armstrong	Senate	Sell	$1,001 - $15,000	Jul 21, 2026

MRSH FAQ

Is MRSH a buy?: Nama's AI scorecard currently rates Marsh & McLennan Companies Buy (6.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is MRSH's P/E ratio?: Marsh & McLennan Companies trades at a trailing price-to-earnings ratio of 19.7.
When does MRSH report earnings?: Marsh & McLennan Companies's next scheduled report is on Jan 28, 2027. Analysts expect EPS of $2.22.
What is the MRSH price target?: The median analyst price target from 21 analysts is $201.00, with a range of $180.00 – $230.00.
Is MRSH Shariah compliant?: Nama's AAOIFI-style screen reads Marsh & McLennan Companies as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does MRSH pay a dividend?: Yes — Marsh & McLennan Companies's dividend yield is 1.9%.